Disruption of NaS1 sulfate transport function in mice leads to enhanced acetaminophen-induced hepatotoxicity

Hepatology

Volumn 43, Issue 6, 2006, Pages 1241-1247

  Lee, Soohyun ^a   Dawson, Paul A ^a   Hewavitharana, Amitha K ^a   Shaw, P Nicholas ^a   Markovich, Daniel ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; GLUCURONIDE; GLUTATHIONE; MESSENGER RNA; PARACETAMOL; PROTEIN NAS 1; SULFATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; HISTOLOGY; HYPERSENSITIVITY; LIVER INJURY; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SULFONATION; WILD TYPE;

EID: 33745567882     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21207     Document Type: Article

References (35)

1. Gill RQ, Sterling RK. Acute liver failure. J Clin Gastroenterol 2001;33:191-198.
2. Mitchell JR, Jollow DJ, Potter SW, Davis DC, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther 1973;187:185-194.
3. Mitchell JR, Jollow DJ, Potter SW, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 1973;187:211-217.
4. Markovich D. Physiological Roles and Regulation of Mammalian Sulfate Transporters. Physiol Rev 2001;81:1499-1534.
5. 2- cotransport. Proc Natl Acad Sci U S A 1993;90:8073-8077.
6. 1 gene. Proc Natl Acad Sci U S A 2003;100:13704-13709.
7. Jackson SG, McCandless EL. Simple, rapid, turbidometric determination of inorganic sulfate and/or protein. Anal Biochem 1978;90:802-808.
8. Manautou JE, Silva VM, Hennig GE, Whiteley HE. Repeated dosing with the peroxisome proliferator clofibrate decreases the toxicity of model hepatotoxic agents in male mice. Toxicology 1998;127:1-10.
9. Morris ME, Levy G. Serum concentration and renal excretion by normal adults of inorganic sulfate after acetaminophen, ascorbic acid, or sodium sulfate. Clin Pharmacol Ther 1983;33:529-536.
10. Kim HJ, Rozman P, Madhu C, Klaassen CD. Homeostasis of sulfate and 3′-phosphoadenosine 5′-phosphosulfate in rats after acetaminophen administration. J. Pharmacol Exp Ther 1992;261:1015-1021.
11. Klassen CD, Boles J. The importance of 3′-phosphoadenosine 5′-phosphosulfate (PAPS) in the regulation of sulfation. FASEB J 1997;11:404-418.
12. Mulder GJ, Jakoby WB: Sulfation. In: Mulder GJ, ed. Conjugation Reactions in Drug Metabolism: An Integrated Approach: Substrates, Co-substrates, Enzymes and Their Interactions In Vivo and In Vitro. London: Taylor and Francis, 1990:107-161.
13. DeLeve LD, Kaplowitz N. Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther 1991;52:287-305.
14. Henderson CJ, Wolf CR, Kitteringham N, Powell H, Otto D, Park BK. Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase pi. Proc Natl Acad Sci U S A 2000;97:12741-12745.
15. Beck L, Markovich D. The mouse Na+-sulfate cotransporter gene Nas1: cloning, tissue distribution, gene structure, chromosomal assignment, and transcriptional regulation by vitamin D. J Biol Chem 2000;275:11880-11890.
16. Fored CM, Ejerblad E, Lindblad P, Fryzek JP, Dickman PW, Signorello LB, et al. Acetaminophen, aspirin, and chronic renal failure. N Engl J Med 2001;345:1801-1808.
17. Hu JJ, Lee MJ, Vapiwala M, Reuhl K, Thomas PE, Yang CS. Sex-related differences in mouse renal metabolism and toxicity of acetaminophen. Toxicol Appl Pharmacol 1993;122:16-26.
18. Blakely P, McDonald BR. Acute renal failure due to acetaminophen ingestion: a case report and review of the literature. J Am Soc Nephrol 1995;6:48-53.
19. Cole DE, Evrovski J. The clinical chemistry of inorganic sulfate. Crit Rev Clin Lab Sci 2000;37:299-344.
20. Hästbacka J, de la Chapelle A, Mahtani M, Clines G, Reeve-Daly M, Daly M, et al. The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell 1994;78:1073-1087.
21. Lee A, Beck L, Markovich D. The mouse sulfate anion transporter gene Sat1 (Slc26a1): cloning, tissue distribution, gene structure, functional characterization, and transcriptional regulation thyroid hormone. DNA Cell Biol 2003;22:19-31.
22. Dahlin DC, Miwa GT, Lu AY, Nelson SD. N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci U S A 1984;81:1327-1331.
23. Zhang J, Huang W, Chua SS, Wei P, Moore DD. Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science 2002;298:422-424.
24. Wu Y, Zhang X, Bardag-Gorce F, Robel RC, Aguilo J, Chen L, et al. Retinoid X receptor alpha regulates glutathione homeostasis and xenobiotic detoxification processes in mouse liver. Mol Pharmacol 2004;65:550-557.
25. Daggett DA, Oberley TD, Nelson SA, Wright LS, Kornguth SE, Siegel FL. Effects of lead on rat kidney and liver: GST expression and oxidative stress. Toxicology 1998;128:191-206.
26. Rumack BH. Acetaminophen misconceptions. HEPATOLOGY 2004;40:10-15.
27. Woo PC, Kaan SK, Cho CH. Evidence for potential application of zinc as an antidote to acetaminophen-induced hepatotoxicity. Eur J Pharmacol 1995;293:217-224.
28. Slattery JT, Levy G. Reduction of acetaminophen toxicity by sodium sulfate in mice. Res Commun Chem Pathol Pharmacol 1977;18:167-170.
29. Price VF, Jollow DJ. Effects of sulfur-amino acid-deficient diets on acetaminophen metabolism and hepatotoxicity in rats. Toxicol Appl Pharmacol 1989;101:356-369.
30. Hindmarsh KW, Mayers DJ, Wallace SM, Danilkewich A, Ernst A. Increased serum sulfate concentrations in man due to environmental factors: effects on acetaminophen metabolism. Vet Hum Toxicol 1991;33:441-445.
31. Steventon G, Heafield M, Waring R, Williams A, Sturman S, Green M. Metabolism of low-dose paracetamol in patients with chronic neurological disease. Xenobiotica 1990;20:117-122.
32. Steventon GB, Waring RH, Williams AC. An investigation into the interrelationships of sulphur xeno-biotransformation pathways in Parkinson's and motor neurone diseases. Drug Metabol Drug Interact 2003;19:223-240.
33. Alberti A, Pirrone P, Elia M, Waring R, Romano C. Sulphation deficit in "low-functioning" autistic children: a pilot study. Biol Psychiatry 1999;46:420-424.
34. Heafield M, Fearn S, Steventon G, Waring R, Williams A, Sturman S. Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. Neurosci Lett 1990;110:216-220.
35. Waring RH, Ngong JM, Klovrza LV, Green S, Sharp H. Biochemical parameters in autistic children. Dev Brain Dysfunct 1997;10:40-43.